Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene

Saved in:
Bibliographic Details
Published in:Revista española de cardiología (English ed.) 2012-11, Vol.65 (11), p.1058
Main Authors: Carrasco, José Ignacio, Izquierdo, Isabel, Medina, Pilar, Arnau, Miguel Ángel, Salvador, Antonio, Zorio, Esther
Format: Article
Language:English
Subjects:
Anti-Arrhythmia Agents - therapeutic use
Cardiac Conduction System Disease
Electrocardiography
Female
Flecainide - therapeutic use
Heterozygote
Humans
Infant
Long QT Syndrome - drug therapy
Long QT Syndrome - genetics
Mutation - physiology
NAV1.5 Voltage-Gated Sodium Channel - genetics
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1885-5857
DOI:10.1016/j.recesp.2012.03.014